Attached files
| file | filename |
|---|---|
| EX-32.0 - EX-32.0 - Aspira Women's Health Inc. | awh-20201231xex32_0.htm |
| EX-31.2 - EX-31.2 - Aspira Women's Health Inc. | awh-20201231xex31_2.htm |
| EX-31.1 - EX-31.1 - Aspira Women's Health Inc. | awh-20201231xex31_1.htm |
| EX-21.0 - EX-21.0 - Aspira Women's Health Inc. | awh-20201231xex21_0.htm |
| EX-4.7 - EX-4.7 - Aspira Women's Health Inc. | awh-20201231xex4_7.htm |
| 10-K - 10-K - Aspira Women's Health Inc. | awh-20201231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Aspira Women’s Health Inc.
Austin, Texas
We hereby consent to the incorporation by reference in the Registration on Form S-3 (Nos. 333-106434, 333-109556, 333-139416, 333-189929, 333-202032, 333-217249, 333-248920, and 333-252267) and Form S-8 (Nos. 333-167204, 333-193312, 333-205855, 333-226462, and 333-232541) of Aspira Women’s Health Inc. (formerly Vermillion, Inc.) of our report dated March 31, 2021, relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ BDO USA, LLP
Austin, Texas
March 31, 2021